BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A
2496 results:

  • 1. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
    Dang J; Xu G; Guo G; Zhang H; Shang L
    J Cancer Res Clin Oncol; 2024 May; 150(5):255. PubMed ID: 38750370
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. High expression of SRSF1 facilitates osteosarcoma progression and unveils its potential mechanisms.
    Li S; Huang X; Zheng S; Zhang W; Liu F; Cao Q
    BMC Cancer; 2024 May; 24(1):580. PubMed ID: 38735973
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Post-surgery statin use contributes to favorable outcomes in patients with early breast cancer.
    Giorello MB; Marks MP; Osinalde TM; Padin MDR; Wernicke A; Calvo JC; Chasseing NA; Vellón L
    Cancer Epidemiol; 2024 Jun; 90():102573. PubMed ID: 38692143
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
    Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
    Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diagnostic accuracy of clinical visual assessment using endoscopic images for nasal cavity mass lesions.
    Kwon KW; Yu MS
    Sci Prog; 2024; 107(2):368504241248004. PubMed ID: 38683182
    [No Abstract]    [Full Text] [Related]  

  • 6. Advancing musculoskeletal tumor diagnosis: Automated segmentation and predictive classification using deep learning and radiomics.
    Wang S; Sun M; Sun J; Wang Q; Wang G; Wang X; Meng X; Wang Z; Yu H
    Comput Biol Med; 2024 Jun; 175():108502. PubMed ID: 38678943
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Regional hyperthermia for soft tissue sarcoma - a survey on current practice, controversies and consensus among 12 European centers.
    Roohani S; Ehret F; Beck M; Veltsista DP; Nadobny J; Zschaeck S; Abdel-Rahman S; Eckert F; Flörcken A; Issels RD; Klöck S; Krempien R; Lindner LH; Notter M; Ott OJ; Pink D; Potkrajcic V; Reichardt P; Riesterer O; Spałek MJ; Stutz E; Wessalowski R; Zilli T; Zips D; Ghadjar P; Kaul D
    Int J Hyperthermia; 2024; 41(1):2342348. PubMed ID: 38653548
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
    Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
    Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Necroptosis-related lncRNA-based novel signature to predict the prognosis and immune landscape in soft tissue sarcomas.
    Long Q; Li Z; Yang W; Huang K; Du G
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):203. PubMed ID: 38635069
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Donor
    Schetelig J; Baldauf H; Heidenreich F; Hoogenboom JD; Spellman SR; Kulagin A; Schroeder T; Sengeloev H; Dreger P; Forcade E; Vydra J; Wagner-Drouet EM; Choi G; Paneesha S; Miranda NAA; Tanase A; de Wreede LC; Lange V; Schmidt AH; Sauter J; Fein JA; Bolon YT; He M; Marsh SGE; Gadalla SM; Paczesny S; Ruggeri A; Chabannon C; Fleischhauer K
    Front Immunol; 2024; 15():1350470. PubMed ID: 38629074
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A CT-based radiomics nomogram for predicting histologic grade and outcome in chondrosarcoma.
    Li X; Shi X; Wang Y; Pang J; Zhao X; Xu Y; Li Q; Wang N; Duan F; Nie P
    Cancer Imaging; 2024 Apr; 24(1):50. PubMed ID: 38605380
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect.
    Murdock HM; Ho VT; Garcia JS
    Front Immunol; 2024; 15():1359113. PubMed ID: 38571944
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Practical 10-Color T-Cell Panel for Phenotyping Diverse Populations Using Spectral Flow Cytometry: A Beginner's Guide.
    Zargaran S; Oveisi M; Sun C; Barbour A; Glogauer M
    Curr Protoc; 2024 Mar; 4(3):e1020. PubMed ID: 38529787
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Automated Detection and Segmentation of bone Metastases on Spine MRI Using U-Net: A Multicenter Study.
    Kim DH; Seo J; Lee JH; Jeon ET; Jeong D; Chae HD; Lee E; Kang JH; Choi YH; Kim HJ; Chai JW
    Korean J Radiol; 2024 Apr; 25(4):363-373. PubMed ID: 38528694
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Combined set7/9 and CDK4 inhibition act synergistically against osteosarcoma.
    Shi Y; Wang Z; Shao Y; Guang Q; Zhang J; Liu B; Wu C; Wang Y; Sui P
    Biochem Biophys Res Commun; 2024 May; 708():149808. PubMed ID: 38520914
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Novel tetrapolar single-needle electrode for electrochemotherapy in bone cavities: Modeling, design and validation.
    Lopes LB; Pintarelli GB; Guedert R; Andrade DLLS; Antonio AC; Ramos CTS; da Silva JR; Rangel MMM; Suzuki DOH
    Med Eng Phys; 2024 Mar; 125():104120. PubMed ID: 38508798
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. HSPA9/mortalin inhibition disrupts erythroid maturation through a TP53-dependent mechanism in human CD34+ hematopoietic progenitor cells.
    Butler C; Dunmire M; Choi J; Szalai G; Johnson A; Lei W; Chen X; Liu L; Li W; Walter MJ; Liu T
    Cell Stress Chaperones; 2024 Apr; 29(2):300-311. PubMed ID: 38508444
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Construction of an oxidative phosphorylation-related gene signature for predicting prognosis and identifying immune infiltration in osteosarcoma.
    Zhou P; Zhang J; Feng J; Wang G
    Aging (Albany NY); 2024 Mar; 16(6):5311-5335. PubMed ID: 38506898
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Construction of a predictive model for bone metastasis from first primary lung adenocarcinoma within 3 cm based on machine learning algorithm: a retrospective study.
    Zhang Y; Xiao L; LYu L; Zhang L
    PeerJ; 2024; 12():e17098. PubMed ID: 38495760
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
    Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
    Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 125.